Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-406-7 | CAS number: 814-80-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- L-(+)-lactic acid
- EC Number:
- 201-196-2
- EC Name:
- L-(+)-lactic acid
- Cas Number:
- 79-33-4
- IUPAC Name:
- 2-hydroxypropanoic acid
- Details on test material:
- SY-83
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Wilmington, MA, USA
- Age at study initiation: young
- Weight at study initiation: 200 g (m) and 219 g (f)
- Fasting period before study: overnight
- Housing: individually in stainless steel, wire-bottomed cages that conformed to the size standards specified in DHEW Publication (NIH) 78.23.
- Diet (e.g. ad libitum): Purina Certified Rodent Chow 5002 was fed to the aniraals ad libitum during the quarantine and study periods except for fasting prior to dosing.
- Water (e.g. ad libitum): Filtered tap water was provided ad libitum through an automatic watering system
- Acclimation period: The animals were quarantined for at least 7 days after receipt.
ENVIRONMENTAL CONDITIONS
The animal rooms were well ventilated and air-conditioned, and the temperature and humidity were monitored daily in these rooms during the quarantine and study periods. The temperature ranged from 68 to 74°F and the relative humidity to 68 percent in all 3 housing rooms with the following exceptions: relative humidity values were recorded as 29 percent on 3 days, 26 percent on one day, and 72 percent on one other day in room 247; and temperatures of 66°F or 67°F were recorded on 3 other days in room 247.
The animal room was lighted from approximately 6:00 a.m. to 6:00 p.m. (12-hour light/12-hour dark cycle) using automatic timers.
IN-LIFE DATES: The study was performed at ToxiGenics, Inc., 1800 East Pershing Road, Decatur, IL 62526 from November 3, 1983 to December 12, 1983.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- In the morning of the days of dosing, body weights were recorded, doses were calculated, and a measured volume of the appropriate test article suspension was delivered to each animal by oral gavage in a single dose. Diet was returned to each surviving animal approximately 4 hours after test article administration.
- Doses:
- 3162, 3548, 3981, 4467, 5012, 5623, 6310 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- The duration of testing was 14 days for range-finding and 14 days or less for each main study dose level.
Animals were observed for mortality and abnormal clinical signs once each hour after dosing on day 0 (to the 4 to 5 hour interval). Observations for mortality and abnormal clinical signs were done twice daily thereafter for the duration of range-finding or main study testing. These twice daily obser- vations were done in the early morning and late afternoon of days l to 13 and in the morning of day 14. Body weights of all range-finding and main study animals were recorded prior to test article administration on the days of dosing (day 0). Body weights were also .recorded on days 7 and 14 for surviving range-finding and main study animals, and at the time found dead for other animals. All surviving range-finding animals were euthanized with carbon dioxide on day 14 and discarded. Range-finding animals found dead were also discarded. Range-finding animals were not examined at necropsy. All surviving main study animals were rendered unconscious with carbon dioxide and exsanguinated prior to necropsy on day 14. All external surfaces, orifices, and organs; cranial cavity; carcass; external and cut surfaces of the brain; abdominal, thoracic, and pelvic cavities and their viscera; and cervical tissues and organs of each main study animal (found dead or sacrificed on day 14) were examined at necropsy and all abnormal findings were recorded. Necropsies were conducted under the supervision of a qualified pathologist. - Statistics:
- The oral LD50 value, the 95 percent confidence interval, the slope of the dose-response curve, and correction factors for 0 and 100 percent observed responses were calculated for each sex by computer program using a method adapted from Litchfield and Wilcoxon . Dose-response curves were prepared by computer program using the calculated LD50 data.
The mean, standard deviation, and Standard error were calculated for the main study body weight and test article administration data (milliliters of suspension administered and calculated milligram values).
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 3 543 mg/kg bw
- 95% CL:
- 9.7
- Remarks on result:
- other: %
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 936 mg/kg bw
- 95% CL:
- 10.8
- Remarks on result:
- other: %
- Mortality:
- All main study mortalties and range-finding mortalities (6,310 mg/kg) occurred after dosing on day 0 or in the morning of day l except for one main study female dosed at 3,162 mg/kg that was found dead in the morning of day 2. Range-finding animals dosed at 1,000, 1,585, 2,512, and 3,981 mg/kg and surviving main study animals were sacrificed after 14-day observation periods.
- Clinical signs:
- other: Lethargy, ataxia, prostration, irregular breathing, piloerection, squinting, lacrimation, salivation, crusty eyes and muzzle, loose stools, damp or yellow/brown stained fur, and moribund were abnormal clinical signs observed for main study animals as earl
- Gross pathology:
- Abnormal necropsy findings were observed for all found dead main study animals, and for the 4 surviving main study females dosed at 3,162 mg/kg. Abnormalities observed during necropsy of found dead animals included: discolored lungs; firm texture of lungs; green foci on one lung; erosion of stomachs; dark, black, brown, and/or fluid contents of stomachs; black and/or brown discolored stomachs; a distended stomach with white mucosa; mucosal sloughing, ulceration, and hemorrhage of stomachs; discolored livers; white foei on livers; pale capsular areas, superficial erosion, or mottled livers; a discolored diaphragm; green-black or brown-black discolored kidneys; and red-brown exudate in the nasal and/or oral regions. Mottled lungs were observed during necropsy of 3 surviving animals dosed at 3,162 mg/kg, and thickened stomachs were also observed during necropsy of 2 surviving animals of the same group. No other abnormalities were observed during necropsy of all main study animals.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral toxicity of lactic acid is clearly less than the limit for classification as harmful
- Executive summary:
Lactic acid was administered to rats by oral gavage. The LD50 is higher than the upper limit for classification (2000 mg/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.